Delivery Order SPE2DB20D3103-SPE2DB23FM9Q2

Award Date 4/3/23
Potential Completion Date 4/4/23
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Humalog 100 unit/mL KwikPen insulin pens to the Defense Logistics Agency (DLA). The $1,119.24 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 18, 2022, with a completion date of February 22, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical...
This federal contract award is for the delivery of Humalog 100 Unit/ML Kwikpen 3ML, a prescription medication, to the Defense Logistics Agency (DLA). The $1,057.28 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 24, 2021, with a completion date of September 27, 2021. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,414.80 fixed-price contract is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a brand-name insulin product. The contract has an ultimate completion date of August 23, 2022 and was awarded on August 22, 2022. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $13,893.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Humalog 100 Unit/mL KwikPen 3mL, a prescription insulin product. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,024.32 firm fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of March 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Humalog 100 Unit/mL Kwikpen 3mL, a brand-name insulin medication, to the Defense Logistics Agency (DLA). The $1,025.97 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 24, 2022, with a completion date of January 25, 2022. The contract is a delivery order placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of Humalog 100 unit/mL KwikPen 3mL, a prescription insulin medication, to unspecified government medical facilities. The $3,072.96 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 13, 2023, with a completion date of February 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,024.32 firm fixed price delivery order is for the supply of Humalog 100 unit/mL Kwikpen 3mL insulin pens. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,459.60 firm fixed-price delivery order is for the supply of Humalog 100 Unit/mL KwikPen 3mL, a critical insulin medication. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,312.48 firm-fixed-price delivery order is for Humalog 100 unit/mL Kwikpen 3mL, a type of insulin medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FM9Q2
    Delivery Order

This federal contract award is for the delivery of Humalog 100 Unit/ML Kwikpen 3ML, a prescription insulin product, to the Defense Logistics Agency (DLA). The $3,072.96 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 3, 2023, with an ultimate completion date of April 4, 2023.

The award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, running through November 2026, enables the efficient government procurement of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other supplies across multiple therapeutic areas. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 9:55 AM